title: Dendritic cell disorders: matters of lineage and clinical drug testing in rare diseases.
authors.affiliation: Children's Center for Cancer and Blood Disorders, Ron Matricaria Institute of Molecular Medicine at Phoenix Children's Hospital, University of Arizona, College of Medicine, Phoenix, AZ rarceci@email.arizona.edu.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Arceci
mesh_terms: D031249:Erdheim-Chester Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000009:adverse effects*; D008297:Male; D058990:Molecular Targeted Therapy; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012867:Skin / Q000187:drug effects*; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf